Skip to main content
Contact Us
Subscribe
E-Edition
76°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vor Biopharma Inc
(NQ:
VOR
)
0.9500
+0.0200 (+2.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vor Biopharma Inc
< Previous
1
2
3
4
5
Next >
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
Vor Bio to Participate in Upcoming Investor Conferences
August 30, 2023
From
Vor Biopharma
Via
GlobeNewswire
The Latest Analyst Ratings for Vor Biopharma
August 14, 2023
Via
Benzinga
What 11 Analyst Ratings Have To Say About Vor Biopharma
June 12, 2023
Via
Benzinga
8 Analysts Have This to Say About Vor Biopharma
May 15, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
During the Friday's sesion, 157 stocks hit new 52-week lows.
Via
Benzinga
Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update
August 10, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Biopharma: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Where Vor Biopharma Stands With Analysts
March 24, 2023
Via
Benzinga
Truist Securities Maintains Buy Rating for Vor Biopharma: Here's What You Need To Know
March 24, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 10, 2023
On Thursday, 128 companies set new 52-week lows.
Via
Benzinga
Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference
August 01, 2023
From
Vor Biopharma
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
July 05, 2023
Wednesday's session saw 43 companies set new 52-week lows.
Via
Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July
July 05, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients
June 09, 2023
Vor Biopharma Inc (NASDAQ: VOR) presented updated data from patients treated in the VBP101 Phase 1/2a study of trem-cel (formerly VOR33) in
Via
Benzinga
Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio’s Platform
June 09, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Participate in the Goldman Sachs Healthcare Conference
June 05, 2023
From
Vor Biopharma
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
May 16, 2023
Via
Benzinga
Vor Bio Reports First Quarter 2023 Financial Results and Provides Company Update
May 11, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
April 18, 2023
From
Vor Biopharma
Via
GlobeNewswire
Dow Rises 50 Points; Oxford Industries Shares Plunge
March 24, 2023
U.S. stocks pared some losses toward the end of trading, with the Dow Jones and S&P 500 turning higher on Friday. The Dow traded up 0.16% to 32,156.53 while the NASDAQ fell 0.16% to 11,768.17. The S&P...
Via
Benzinga
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 24, 2023
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.
Via
Benzinga
Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
March 23, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
February 21, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Biopharma's Leukemia Cell Exhibits Favorable Engraftment Five Months Post-Transplant
February 16, 2023
Via
Benzinga
First AML Patient Transplanted with Vor Bio’s Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level
February 16, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings
January 19, 2023
From
Vor Biopharma
Via
GlobeNewswire
Vor Bio to Present at B. Riley Securities’ 3rd Annual Oncology Conference
January 12, 2023
From
Vor Biopharma
Via
GlobeNewswire
Analyzing Vor Biopharma's Short Interest
January 10, 2023
Vor Biopharma's (NASDAQ:VOR) short percent of float has fallen 58.58% since its last report. The company recently reported that it has 2.53 million shares sold short, which is 5.31% of all regular...
Via
Benzinga
Dow Edges Higher; Prometheus Biosciences Shares Jump
December 07, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 0.5% on Wednesday.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.